← Back to headlines
Merck and Rivals Reportedly Interested in Inhibrx Cancer Drug
Pharmaceutical giant Merck and other rival companies are reportedly showing interest in acquiring Inhibrx's cancer drug, signaling potential major developments in the oncology market.
22 Apr, 12:37 — 22 Apr, 12:37
Sources
Showing 1 of 1 sources
Related Stories
'Astronauts back on Earth': Artemis II crew splashes down after record-breaking moon flyby – video
just now
Chernobyl Disaster's Legacy and Future Risk Assessment
19m ago
Climate Change Extends Wildfire Burn Times, Especially in California
37m ago
Professor Lada Lukić Bilela Lectures on Dinarides' Underground Biodiversity
41m ago